Ajer Jeffrey Robert — SEC Form 4 filings
SEC reporting owner CIK 1557533. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-29 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 9,000 shares, $762,830 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 5,000 shares @ $82.91 ($414,550) in BIOMARIN PHARMACEUTICAL INC, filed 2024-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | EVP, Chief Commercial Officer | 4 | — | 2 legs · 9,000 sh · $762,830 | 5 |
| Viridian Therapeutics, Inc.\DE (VRDN) | Director | 3 | — | — | 3 |
| NEKTAR THERAPEUTICS (NKTR) | Director | 1 | — | — | 1 |
Form 4 filings — Ajer Jeffrey Robert
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 32,341 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 300 @ $68.65 · Sale (S): 5,000 @ $82.91 | EDGAR |
| 2024-03-19 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax withholding (F): 22,580 @ $83.87 | EDGAR |
| 2024-03-07 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale (S): 4,000 @ $87.07 | EDGAR |
| 2024-02-29 | 4 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/award (A): 21,440 @ $0 · Grant/award (A): 9,338 @ $0 · Grant/award (A): 6,465 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1557533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →